Zoetis Inc. · NYSE:ZTS
Zoetis — Cowen Presentation (September 2017)
10 slides from Zoetis's conference presentation, September 2017
Slide 1: Positioning Zoetis for Sustainable Growth and Value Creation
POSITIONING ZOETIS FOR SUSTAINABLE GROWTH AND VALUE CREATION CLINT LEWIS EVP & PRESIDENT 1 INTERNATIONAL OPERATIONS
Slide 2: Forward-Looking Statements; Non-GAAP Financial Information
FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, future guidance, future operating models, expectations regarding products, future use of
Slide 3: Agenda
AGENDA • STABLE AND GROWING ANIMAL HEALTH INDUSTRY • CONTINUING THE ZOETIS JOURNEY • DIVERSITY OF INTERNATIONAL SEGMENT • DRIVING INTERNATIONAL RESULTS 3
Slide 4: Animal Health Industry Fundamentals
ANIMAL HEALTH INDUSTRY FUNDAMENTALS AT THE CORE OF A $100+ BILLION PREDICTABLE, SUSTAINABLE AND INDUSTRY FUNDAMENTAL GROWTH DRIVERS POPULATION GROWTH ANIMAL HEALTH 1 COMPANION ~$30 Billion LIVESTOCK ANIMAL • Medicines • Nutrition A RISING • Pet Supplies • Vaccines • Genetics • Vet Services • Medicat
Slide 5: The Zoetis Journey
THE ZOETIS JOURNEY 2013 - 2014 2015 - 2016 2017 STAGE ONE STAGE TWO STAGE THREE • Separation from Pfizer • Commence operational efficiency • Complete operational efficiency initiative initiative • Establishment of our own processes, systems and manufacturing network • Reduce complexity, re-allocate
Slide 6: Industry Leading Revenue Growth with Improving Margins
INDUSTRY LEADING REVENUE GROWTH WITH IMPROVING MARGINS • Despite industry consolidation, Zoetis ZOETIS REVENUE OPERATIONAL1 GROWTH RATES & ADJUSTED EBIT MARGIN2 remains global leader based on total 8% 34.5% sales 32% 7% 7% 6.5% 28% • Grown sales faster than market over 25% 5% 24% four-year period •
Slide 7: Diverse Species Portfolio Across International Markets
DIVERSE SPECIES PORTFOLIO ACROSS INTERNATIONAL MARKETS DIVERSIFIED REGIONAL REVENUE TARGETS KEY SPECIES 2016 INTERNATIONAL SEGMENT REVENUE – BY SPECIES 3% 4%3% Companion Animal Dogs/Cats 12% 28% Equine Livestock Cattle Swine 17% Poultry Fish 33% Other 7 2016 Revenue: $2,390M 7
Slide 8: Diversified Revenue Across Key Markets
DIVERSIFIED REVENUE ACROSS KEY MARKETS 245 2016 Revenue by Top International Markets ($M) 173 157 151 145 125 127 117 83 82 76 Brazil Canada Australia UK China Japan Germany France Italy Spain Mexico Key Market Brazil Canada Australia UK China Japan Germany France Italy Spain Mexico Figures Livestoc
Slide 9: Driving International Results
DRIVING INTERNATIONAL RESULTS IMPROVING OUR PROCESSES AND STRATEGIC FOCUS Simplified Operating Model Focused Investment in Key Markets • Streamlined regional infrastructure to • Better positioned to support key emerging better focus efforts on the customer markets (Brazil and China) • Leverage U.S.
Slide 10: Zoetis
zoetis